Wockhardt will exit its loss-making generics business in the US as part of its strategy to enhance focus on innovation with new antibiotic drug discovery and biologics portfolio in insulin. ET was the first to report on...
Merck to acquire Verona Pharma for $10 billion
Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s presence in respiratory treatments as it readies for the patent expiry of its blockbuster...
Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr
Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd, for Rs 1,290 crore. The company has signed a...
Torrent Pharma to acquire additional 2.41% stake in JB Chemicals for Rs 620 crore
Ahmedabad-based drug maker Torrent Pharmaceuticals Ltd has signed a share purchase agreement to acquire an additional 2.41% stake in J.B. Chemicals & Pharmaceuticals Ltd from employees for a total cash consideration...
Torrent Pharma set to finalise JB Chemicals buyout in 15-18 months
Ahmedabad-based drug maker Torrent Pharmaceuticals will complete its acquisition of JB Chemicals & Pharmaceuticals in the next 15-18 months subject to key regulatory approvals, a top company executive said in an...
AbbVie to buy Capstan for up to $2.1 billion in immunology push
AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments for autoimmune diseases...
Torrent Pharma to acquire JB Chemicals at Rs 25,689 crore valuation
Ahmedabad-based drugmaker Torrent Pharma has agreed to buy a controlling stake in JB Chemicals from global private equity firm KKR at an equity valuation of Rs 25,689 crore ($3 billion). The deal, which will see a...
Torrent Pharma closes in on JB Chem likely for $2.4 bn buyout, eyes $1.6 billion financing
Torrent Pharma is in advanced discussions with private equity group KKR to buy JB Chemicals and Pharmaceuticals, almost 10 months after their initial discussions fell through, said multiple people aware. KKR the...
Eli Lilly to acquire gene-editing biotech company Verve Therapeutics for $1.3 billion
US-based multinational pharmaceutical giant Eli Lilly & Co., on Tuesday, 17 June 2025, announced its plans to acquire gene-editing biotech firm Verve Therapeutics Inc. for $1.3 billion as the big pharma company eyes...
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy
Bristol Myers Squibb (BMY.N) has agreed to pay up to $11.1 billion to partner with Germany’s BioNTech and develop the latter’s next-generation cancer immunotherapy, which could take on rival Merck &...
Sun Pharma’s Checkpoint buy: Why it’s a strategic fit in the new SPIL focus
India’s largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint Therapeutics for approximately $355 million. This strategic move significantly strengthens Sun Pharma’s...
Sanofi finds M&A fix for its multiple itches
LONDON, June 2 (Reuters Breakingviews) – Sanofi is one European giant that’s still focused on the United States. The $123 billion French drugmaker will pay up to $9.5 billion, for Blueprint Medicines, a U.S. group...
